Department of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Department of Pathology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Chest. 2021 May;159(5):1768-1781. doi: 10.1016/j.chest.2021.02.006. Epub 2021 Feb 10.
Primary ciliary dyskinesia (PCD) is a heterogeneous disease with a diverse clinical and genetic spectrum among populations worldwide. Few cases of pediatric PCD have been reported from China.
What are the clinical and genotypic characteristics of children with PCD in China?
Clinical characteristics, laboratory findings, and genetic results obtained for 75 patients with PCD were reviewed retrospectively at a single center in China. Genetic sequencing was conducted using whole-exome screening.
Patient median age at diagnosis was 7.0 years (range, 2 months-14 years). Of 75 patients, 88% (66/75) had chronic wet cough, 77% (58/75) had recurrent sinusitis, 76% (57/75) had bronchiectasis, 40% (30/75) had neonatal respiratory distress, and 28% (21/75) had coexistent asthma. Notably, postinfectious bronchiolitis obliterans (PIBO) as first presentation was found in 8% of children (6/75). Genes with the highest incidence of mutations were DNAH11 (15/51), followed by DNAH5 (9/51), CCDC39 (5/51), DNAH1 (4/51), and CCNO (3/51). Four genes (DNAI1, HEATR2, RSPH9, and DNAAF3) each were respectively found in two patients, and seven genes (CCDC40, LRRC6, SPAG1, RSPH4A, ARMC4, CCDC114, and DNAH14, a novel gene) each were mutated once. No differences in classical clinical features were observed among patients with commonly observed PCD-associated genotypes. However, three of six PIBO patients carried DNAH1 mutations.
Besides typical clinical features, PIBO was observed as the first presentation of pediatric PCD in China. An association of the novel gene DNAH14 with PCD was observed, expanding the PCD genotypic spectrum.
原发性纤毛运动障碍(PCD)是一种异质性疾病,在全球人群中的临床表现和遗传谱均存在多样性。中国仅有少数儿童 PCD 病例报道。
中国儿童 PCD 的临床和基因型特征是什么?
回顾性分析了在中国一家中心医院就诊的 75 例 PCD 患者的临床特征、实验室检查结果和基因检测结果。采用全外显子组测序进行基因测序。
患者中位诊断年龄为 7.0 岁(范围,2 个月-14 岁)。75 例患者中,88%(66/75)有慢性湿性咳嗽,77%(58/75)有复发性鼻窦炎,76%(57/75)有支气管扩张,40%(30/75)有新生儿呼吸窘迫,28%(21/75)有并存哮喘。值得注意的是,8%(6/75)的患儿以感染后细支气管炎性闭塞(PIBO)为首发表现。突变发生率最高的基因依次为 DNAH11(15/51)、DNAH5(9/51)、CCDC39(5/51)、DNAH1(4/51)和 CCNO(3/51)。4 个基因(DNAI1、HEATR2、RSPH9 和 DNAAF3)各在 2 例患者中发现,7 个基因(CCDC40、LRRC6、SPAG1、RSPH4A、ARMC4、CCDC114 和 DNAH14,一个新基因)各突变 1 次。在常见的 PCD 相关基因型患者中,经典的临床特征无差异。然而,6 例 PIBO 患者中有 3 例携带 DNAH1 突变。
除了典型的临床特征外,PIBO 也可作为中国儿童 PCD 的首发表现。观察到新型基因 DNAH14 与 PCD 相关,扩大了 PCD 的基因型谱。